欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/H/0239/001
药品名称
MYFORTIC 180mg
活性成分
[No Active-Substance specified] 0.0 -
剂型
Gastro-resistant tablet
上市许可持有人
Novartis Pharma SAS
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Iceland (IS)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Myfortic 180 mg - magensaftresistente Filmtabletten
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Sweden (SE)
Norway (NO)
Finland (FI)
Poland (PL)
Myfortic 180 mg powlekane tabletki dojelitowe
Hungary (HU)
Cyprus (CY)
MYFORTIC GASTRO RESISTANT TABS 180mg
Czechia (CZ)
Slovakia (SK)
Slovenia (SI)
Malta (MT)
许可日期
2004/02/07
最近更新日期
2024/05/28
药物ATC编码
L04AA06 mycophenolic acid
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
common_combined_clean_360mg_2
Date of last change:2024/05/08
Final Product Information
|
common_combined_clean_360mg
Date of last change:2024/05/08
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase